NCT04523428
- Conditions
- CLL/SLL
- Locations
-
- BE-Bruxelles-STLUC Brussels, Belgium
- BE-Leuven-UZLEUVEN Leuven, Belgium
- DK-Aarhus N-AUH Aarhus, Denmark
- NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
Clinical trial condition
CLL/SLL
Explore clinical trials studying CLL/SLL. Study availability and eligibility vary by location and protocol.
14 public trials
9 recruiting studies
CLL/SLL trial results
NCT06319456
- Conditions
- CLL/SLL
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- The affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China
NCT06104566
- Conditions
- CLL/SLL
- Locations
-
- Ascentage Investigative Site Tuscon, Arizona, United States
- Ascentage Investigative Site Anaheim, California, United States
- Ascentage Investigative Site Jacksonville, Florida, United States
- Ascentage Investigative Site Miami Beach, Florida, United States
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
NCT04775745
- Conditions
- Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
- Locations
-
- Duke Univerisity Durham, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State University Columbus, Ohio, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
NCT07108998
- Conditions
- CLL, CLL/SLL, Chronic Disease, +20 more
- Locations
-
- University of Cincinnati Cincinnati, Ohio, United States
NCT06978088
- Conditions
- CLL/SLL, Chronic Disease, Chronic Lymphocytic Leukemia, +17 more
- Locations
-
- University of Cincinnati Medical Center Cincinnati, Ohio, United States
Recruiting
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
NCT04215809
- Conditions
- CLL/SLL
- Locations
-
- City of Hope Duarte, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Novant Health Charlotte, North Carolina, United States
NCT06508684
- Conditions
- CLL/SLL
- Locations
-
- Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital Nanjin, Jiangsu, China
NCT05791409
- Conditions
- CLL/SLL
- Locations
-
- BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
- BE-Roeselare-AZDELTA Roeselare, Belgium
- DK-Aalborg-ALBOGUH Aalborg, Denmark
- DK-Copenhagen-RIGSHOSPITALET Copenhagen, Denmark
Not yet recruiting
A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy
NCT06476899
- Conditions
- CLL/SLL
- Locations
-
Not specified